FDA Approves Cancer Drugs Faster Than Other Treatments

cp418

http://www.pharmalot.com/2012/09/fda-oks-cancer-drugs-faster-than-other-meds/

Analysis: FDA Approves Cancer Drugs Faster Than Other Treatments.

Pharmalot (9/7, Silverman) reported that according to an analysis by the Tufts Center for the Study of Drug Development, FDA approval times for cancer medications "between 2007 and 2011 took 10 months less than for other drugs, while approval times by the European Medicines Agency took two months less time." In other words, the EMA "took 54 percent more time to approve cancer meds, although the EMA took 27 percent less time to approve other drugs"; and cancer drugs as a "share of total approvals at the FDA and the EMA were 19 percent and 12 percent, respectively." The study also found that "orphan designations for cancer meds in the US rose during the past decade, but the share of fast track and accelerated approval designations dropped sharply."